Novartis, Bayer and patent drafting: what’s on this week

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Novartis, Bayer and patent drafting: what’s on this week

Managing IP lists the IP events and lawsuits taking place this week



Tuesday August 21, 2012


The IP Office of the Philippines will be holding a course, Patent Drafting II, for examination passers only, location TBC

Hearing before India’s Intellectual Property Appellate Board in Natco v Bayer, concerning the compulsory license granted to Natco to manufacture generic versions of Bayer’s sorafenib.

Wednesday August 22


India’s Supreme Court is due to hear final arguments between Switzerland’s Novartis against India's patent office over its refusal to grant a patent over cancer drug Glivec.

The USPTO is seeking volunteers to test the new electronic filing system for administrative trials linked to post grant review, inter partes review and the transitional programme for covered business methods.

Friday August 24, 2012


The IP Office of the Philippines will be hosting a meeting with the Japan-Asia Young Scientist & Engineer Study (JAYSES) at its offices in Taguig City.

Last day of Apple v Samsung trial in California.



more from across site and SHARED ros bottom lb

More from across our site

New partners, from biotech company Leyden Labs and Novartis, take the total number of partner hires to 12 since the firm took on external investment in late 2024
Labelled the ‘largest law firm merger in history’, the new outfit could also spell an opportunity for US clients to capitalise on Hogan Lovells' UPC expertise
Andy Lee and Amy Brooks of Brandsmiths explain how the firm secured a win for Peppa Pig over rival children’s character Wolfoo, in a case that centred on copied audio clips
Pedro Moreira outlines proposals by INPI that look set to open a discussion regarding biological materials, extracts, sequences, genetically edited plants, and computer programs
The combined firm, which has a newly appointed IP partner in London, brings together more than 3,500 practitioners across 52 offices, with flagship hubs in Seattle, London, Sydney and New York
A host of SEP-rich law firms, both leading arguments and as intervenors, are set to feature in the UK Supreme Court’s third FRAND episode, though one ground of appeal has been settled
Law firms are investing in generative engine optimisation and boosting their online presence in the hope of gaining a new client base
A decision on a licensing rate payable by Warner Bros and Paramount, and a survey outlining UK businesses’ lack of IP preparation ahead of launching abroad, were among other major talking points
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Gift this article